ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Viral Vectored Vaccine Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-10S11237
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Veterinary Viral Vectored Vaccine Market Research Report 2022
BUY CHAPTERS

Global Veterinary Viral Vectored Vaccine Market Research Report 2025

Code: QYRE-Auto-10S11237
Report
January 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim
Ceva

Veterinary Viral Vectored Vaccine Market Size

According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021.

Veterinary Viral Vectored Vaccine Market

Veterinary Viral Vectored Vaccine Market

The global market for Veterinary Viral Vectored Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 551%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Viral Vectored Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Viral Vectored Vaccine.
The Veterinary Viral Vectored Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Viral Vectored Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Viral Vectored Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Viral Vectored Vaccine Market Report

Report Metric Details
Report Name Veterinary Viral Vectored Vaccine Market
Accounted market size in 2021 $ 38.3 billion
Base Year 2021
Segment by Type
Segment by Application
  • Pet
  • Chicken
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer-Ingelheim, Ceva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Viral Vectored Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Viral Vectored Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Veterinary Viral Vectored Vaccine Market share by application?

Ans: From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%.

Who are the main players in the Veterinary Viral Vectored Vaccine Market report?

Ans: The main players in the Veterinary Viral Vectored Vaccine Market are Boehringer-Ingelheim, Ceva

What are the Application segmentation covered in the Veterinary Viral Vectored Vaccine Market report?

Ans: The Applications covered in the Veterinary Viral Vectored Vaccine Market report are Pet, Chicken, Others

What are the Type segmentation covered in the Veterinary Viral Vectored Vaccine Market report?

Ans: The Types covered in the Veterinary Viral Vectored Vaccine Market report are Alphaherpesvirus (HVT) Vector, Canarypox Vector, Vaccinia Vector

Recommended Reports

Veterinary Equipment

Veterinary Drugs

Pet Health Market

1 Veterinary Viral Vectored Vaccine Market Overview
1.1 Product Definition
1.2 Veterinary Viral Vectored Vaccine by Type
1.2.1 Global Veterinary Viral Vectored Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Alphaherpesvirus (HVT) Vector
1.2.3 Canarypox Vector
1.2.4 Vaccinia Vector
1.3 Veterinary Viral Vectored Vaccine by Application
1.3.1 Global Veterinary Viral Vectored Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Pet
1.3.3 Chicken
1.3.4 Others
1.4 Global Veterinary Viral Vectored Vaccine Market Size Estimates and Forecasts
1.4.1 Global Veterinary Viral Vectored Vaccine Revenue 2020-2031
1.4.2 Global Veterinary Viral Vectored Vaccine Sales 2020-2031
1.4.3 Global Veterinary Viral Vectored Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary Viral Vectored Vaccine Market Competition by Manufacturers
2.1 Global Veterinary Viral Vectored Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Viral Vectored Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary Viral Vectored Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary Viral Vectored Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Date of Enter into This Industry
2.8 Global Veterinary Viral Vectored Vaccine Market Competitive Situation and Trends
2.8.1 Global Veterinary Viral Vectored Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Viral Vectored Vaccine Players Market Share by Revenue
2.8.3 Global Veterinary Viral Vectored Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Viral Vectored Vaccine Market Scenario by Region
3.1 Global Veterinary Viral Vectored Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary Viral Vectored Vaccine Sales by Region: 2020-2031
3.2.1 Global Veterinary Viral Vectored Vaccine Sales by Region: 2020-2025
3.2.2 Global Veterinary Viral Vectored Vaccine Sales by Region: 2026-2031
3.3 Global Veterinary Viral Vectored Vaccine Revenue by Region: 2020-2031
3.3.1 Global Veterinary Viral Vectored Vaccine Revenue by Region: 2020-2025
3.3.2 Global Veterinary Viral Vectored Vaccine Revenue by Region: 2026-2031
3.4 North America Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
3.4.1 North America Veterinary Viral Vectored Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary Viral Vectored Vaccine Sales by Country (2020-2031)
3.4.3 North America Veterinary Viral Vectored Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
3.5.1 Europe Veterinary Viral Vectored Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary Viral Vectored Vaccine Sales by Country (2020-2031)
3.5.3 Europe Veterinary Viral Vectored Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Viral Vectored Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Viral Vectored Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary Viral Vectored Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary Viral Vectored Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
3.7.1 Latin America Veterinary Viral Vectored Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary Viral Vectored Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Veterinary Viral Vectored Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Viral Vectored Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary Viral Vectored Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary Viral Vectored Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Viral Vectored Vaccine Sales by Type (2020-2031)
4.1.1 Global Veterinary Viral Vectored Vaccine Sales by Type (2020-2025)
4.1.2 Global Veterinary Viral Vectored Vaccine Sales by Type (2026-2031)
4.1.3 Global Veterinary Viral Vectored Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Viral Vectored Vaccine Revenue by Type (2020-2031)
4.2.1 Global Veterinary Viral Vectored Vaccine Revenue by Type (2020-2025)
4.2.2 Global Veterinary Viral Vectored Vaccine Revenue by Type (2026-2031)
4.2.3 Global Veterinary Viral Vectored Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary Viral Vectored Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary Viral Vectored Vaccine Sales by Application (2020-2031)
5.1.1 Global Veterinary Viral Vectored Vaccine Sales by Application (2020-2025)
5.1.2 Global Veterinary Viral Vectored Vaccine Sales by Application (2026-2031)
5.1.3 Global Veterinary Viral Vectored Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Veterinary Viral Vectored Vaccine Revenue by Application (2020-2031)
5.2.1 Global Veterinary Viral Vectored Vaccine Revenue by Application (2020-2025)
5.2.2 Global Veterinary Viral Vectored Vaccine Revenue by Application (2026-2031)
5.2.3 Global Veterinary Viral Vectored Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary Viral Vectored Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer-Ingelheim
6.1.1 Boehringer-Ingelheim Company Information
6.1.2 Boehringer-Ingelheim Description and Business Overview
6.1.3 Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Product Portfolio
6.1.5 Boehringer-Ingelheim Recent Developments/Updates
6.2 Ceva
6.2.1 Ceva Company Information
6.2.2 Ceva Description and Business Overview
6.2.3 Ceva Veterinary Viral Vectored Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ceva Veterinary Viral Vectored Vaccine Product Portfolio
6.2.5 Ceva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Viral Vectored Vaccine Industry Chain Analysis
7.2 Veterinary Viral Vectored Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Viral Vectored Vaccine Production Mode & Process Analysis
7.4 Veterinary Viral Vectored Vaccine Sales and Marketing
7.4.1 Veterinary Viral Vectored Vaccine Sales Channels
7.4.2 Veterinary Viral Vectored Vaccine Distributors
7.5 Veterinary Viral Vectored Vaccine Customer Analysis
8 Veterinary Viral Vectored Vaccine Market Dynamics
8.1 Veterinary Viral Vectored Vaccine Industry Trends
8.2 Veterinary Viral Vectored Vaccine Market Drivers
8.3 Veterinary Viral Vectored Vaccine Market Challenges
8.4 Veterinary Viral Vectored Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim
Ceva
List of Tables
 Table 1. Global Veterinary Viral Vectored Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Veterinary Viral Vectored Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Veterinary Viral Vectored Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Veterinary Viral Vectored Vaccine Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Veterinary Viral Vectored Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Veterinary Viral Vectored Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Veterinary Viral Vectored Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Veterinary Viral Vectored Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Viral Vectored Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Viral Vectored Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Viral Vectored Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Veterinary Viral Vectored Vaccine Sales by Region (2020-2025) & (Units)
 Table 18. Global Veterinary Viral Vectored Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Veterinary Viral Vectored Vaccine Sales by Region (2026-2031) & (Units)
 Table 20. Global Veterinary Viral Vectored Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Veterinary Viral Vectored Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Veterinary Viral Vectored Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Veterinary Viral Vectored Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Veterinary Viral Vectored Vaccine Sales by Country (2020-2025) & (Units)
 Table 27. North America Veterinary Viral Vectored Vaccine Sales by Country (2026-2031) & (Units)
 Table 28. North America Veterinary Viral Vectored Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Veterinary Viral Vectored Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Veterinary Viral Vectored Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Veterinary Viral Vectored Vaccine Sales by Country (2020-2025) & (Units)
 Table 32. Europe Veterinary Viral Vectored Vaccine Sales by Country (2026-2031) & (Units)
 Table 33. Europe Veterinary Viral Vectored Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Veterinary Viral Vectored Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Veterinary Viral Vectored Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Veterinary Viral Vectored Vaccine Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Veterinary Viral Vectored Vaccine Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Veterinary Viral Vectored Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Veterinary Viral Vectored Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Veterinary Viral Vectored Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Veterinary Viral Vectored Vaccine Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Veterinary Viral Vectored Vaccine Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Veterinary Viral Vectored Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Veterinary Viral Vectored Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Veterinary Viral Vectored Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Veterinary Viral Vectored Vaccine Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Veterinary Viral Vectored Vaccine Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Veterinary Viral Vectored Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Viral Vectored Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Veterinary Viral Vectored Vaccine Sales (Units) by Type (2020-2025)
 Table 51. Global Veterinary Viral Vectored Vaccine Sales (Units) by Type (2026-2031)
 Table 52. Global Veterinary Viral Vectored Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Veterinary Viral Vectored Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Veterinary Viral Vectored Vaccine Sales (Units) by Application (2020-2025)
 Table 61. Global Veterinary Viral Vectored Vaccine Sales (Units) by Application (2026-2031)
 Table 62. Global Veterinary Viral Vectored Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Veterinary Viral Vectored Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Boehringer-Ingelheim Company Information
 Table 71. Boehringer-Ingelheim Description and Business Overview
 Table 72. Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Product
 Table 74. Boehringer-Ingelheim Recent Developments/Updates
 Table 75. Ceva Company Information
 Table 76. Ceva Description and Business Overview
 Table 77. Ceva Veterinary Viral Vectored Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ceva Veterinary Viral Vectored Vaccine Product
 Table 79. Ceva Recent Developments/Updates
 Table 80. Key Raw Materials Lists
 Table 81. Raw Materials Key Suppliers Lists
 Table 82. Veterinary Viral Vectored Vaccine Distributors List
 Table 83. Veterinary Viral Vectored Vaccine Customers List
 Table 84. Veterinary Viral Vectored Vaccine Market Trends
 Table 85. Veterinary Viral Vectored Vaccine Market Drivers
 Table 86. Veterinary Viral Vectored Vaccine Market Challenges
 Table 87. Veterinary Viral Vectored Vaccine Market Restraints
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Viral Vectored Vaccine
 Figure 2. Global Veterinary Viral Vectored Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Veterinary Viral Vectored Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Alphaherpesvirus (HVT) Vector Product Picture
 Figure 5. Canarypox Vector Product Picture
 Figure 6. Vaccinia Vector Product Picture
 Figure 7. Global Veterinary Viral Vectored Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Veterinary Viral Vectored Vaccine Market Share by Application: 2024 & 2031
 Figure 9. Pet
 Figure 10. Chicken
 Figure 11. Others
 Figure 12. Global Veterinary Viral Vectored Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Veterinary Viral Vectored Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Veterinary Viral Vectored Vaccine Sales (2020-2031) & (Units)
 Figure 15. Global Veterinary Viral Vectored Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 16. Veterinary Viral Vectored Vaccine Report Years Considered
 Figure 17. Veterinary Viral Vectored Vaccine Sales Share by Manufacturers in 2024
 Figure 18. Global Veterinary Viral Vectored Vaccine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Veterinary Viral Vectored Vaccine Players: Market Share by Revenue in Veterinary Viral Vectored Vaccine in 2024
 Figure 20. Veterinary Viral Vectored Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Veterinary Viral Vectored Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Veterinary Viral Vectored Vaccine Sales Market Share by Country (2020-2031)
 Figure 23. North America Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2020-2031)
 Figure 24. United States Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Veterinary Viral Vectored Vaccine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Veterinary Viral Vectored Vaccine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Veterinary Viral Vectored Vaccine Revenue Market Share by Region (2020-2031)
 Figure 35. China Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Veterinary Viral Vectored Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Veterinary Viral Vectored Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Veterinary Viral Vectored Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Veterinary Viral Vectored Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Veterinary Viral Vectored Vaccine by Type (2020-2031)
 Figure 56. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Veterinary Viral Vectored Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Veterinary Viral Vectored Vaccine by Application (2020-2031)
 Figure 59. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 60. Veterinary Viral Vectored Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Animal Biological Vaccine Market Research Report 2024
Global Live Attenuated Veterinary Vaccines Market Research Report 2024
Pet Food Launcher Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibiotics for Dogs and Cats Market Research Report 2025
Veterinary Anti Infectives Market
Veterinary Smart Syringe Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dog Vitamins Market Insights Forecast to 2030
Animal Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Electrosurgical Instrument Market Research Report 2025
Global Insects as Animal Feed Market Insights Forecast to 2030
Global Prescription Weight Loss Pet Food Market Research Report 2025
Digital Veterinary Radiography Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Subscription and Fresh Dog Food Market Research Report 2025
Vaccination for Animal Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Genetic Engineering Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Genetic Engineering Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Feed Additives for Ruminants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Medical Examination Equipment Market Research Report 2025
Global Veterinary Coagulation Analyser Market Research Report 2025
Global Vet Clinic Software Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions